Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and the β-galactosidase gene in the noninfarcted area, but not the myocardial infarcted area

Gene Therapy

Volumn 4, Issue 2, 1997, Pages 120-127

  Aoki, M ^a   Morishita, R ^a   Higaki, J ^a   Moriguchi, A ^a   Hayashi, S ^a   Matsushita, H ^a   Kida, I ^a   Tomita, N ^a   Sawa, Y ^a   Kaneda, Y ^a   Ogihara, T ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Angiogenesis; Cardiomyocytes; Gene therapy; HVJ liposome method

Indexed keywords

BETA GALACTOSIDASE; OLIGODEOXYNUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; GENE THERAPY; GENETIC TRANSFECTION; GRAFT FAILURE; GRAFT SURVIVAL; HEART INFARCTION; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 8044254628     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300361     Document Type: Article

References (33)

1. Anderson WF. Human gene therapy. Science 1992; 256: 808-813.
2. Miller AD. Human gene therapy comes of age. Nature 1992; 357: 455-460.
3. Dzau VJ, Morishita R, Gibbons GH. Gene therapy in the cardio-vascular diseases. Trends Biotechnol 1993; 11: 205-210.
4. Koh GY, Klug MG, Soonpaa MH, Field LJ Differentiation and long-term survival of C2C12 myoblast grafts in heart. J Clin Invest 1993; 92: 1548-1554.
5. Koh GY et al Targeted expression of transforming growth factor-b1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis. J Clin Invest 1995; 95: 114-121.
6. Soonpaa MH, Koh GY, Klug MG, Field LJ. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 1994; 264: 98-101
7. Morishita R et al. Single intraluminal delivery of antisense cdc 2 kinase and proliferating cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci USA 1993; 90: 8474-8478.
8. Morishita R et al. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest 1994; 93: 1458-1464.
9. Morishita R et al. Pharmacokinetics of antisense oligonucleotides (cyclin B1 and cdc 2 kinase) in the vessel wall: enhanced therapeutic utility for restenosis by HVJ-liposome method- Gene 1994; 149: 13-19.
10. Morishita R et al. A novel molecular strategy using cis element 'decoy' of E2F binding site inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci USA 1995; 92: 5855-5859.
11. Simons M et al. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 1992; 359: 67-80.
12. Leyen HVL et al. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of nitric oxide synthase gene. Proc Natl Acad Sci USA 1995; 92: 1137-1141.
13. Ohno T et al. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 1994; 265: 781-784.
14. Chang MW et al. Cytostatic gene therapy for vascular proliferative disorder constitutively active form of the retinoblastoma gene product. Science 1995; 267: 518-522.
15. Acsadi G et al. Direct gene transfer and expression into rat heart in vivo. New Biologist 1991; 3: 71-81.
16. Buttric PM et al. Behavior of genes directly injected into the rat heart in vivo. Circ Res 1992; 70: 193-198.
17. Gal D et al. Direct myocardial transfection in two animal models evaluation of parameters affecting gene expression and percutaneous gene delivery. Lab Invest 1993, 68: 18-25.
18. Harsdorf RV et al. Gene injection into canine myocardium as a useful model for studying gene expression in the heart of large mammals. Circ Res 1993; 72: 688-695.
19. Lin H et al. Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation 1990; 82: 2217-2221.
20. Kitsis RN et al. Hormonal modulation of a gene injected into rat heart in vivo. Proc Natl Acad Sci USA 1991; 88: 4138-4142.
21. Barr E et al. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Therapy 1994; 1: 51-58.
22. French BA, Mazur W, Geske RS, Bolli R. Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation 1994; 90: 2414-2424.
23. Guzman RJ et al. Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ Res 1993; 73: 1202-1207.
24. Kirshenbaum LA et al. Highly efficient gene transfer into adult ventricular myocytes by recombinant adenovirus. J Clin Invest 1993; 92: 381-387.
25. Schneider MD, French BA. The advent of adenovirus gene therapy for cardiovascular disease. Circulation 1993; 88: 1937-1942.
26. Nakanishi M et al. Efficient introduction of contents of liposomes into cell using HVJ (Sendai virus). Exp Cell Res 1985; 159: 399-409.
27. Kaneda Y, Iwai K, Uchida T. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 1989, 243: 375-378.
28. Robinson TF et al. Morphology, composition, and function of struts between cardiac myocytes of rat and hamster Cell Tissue Res 1987, 249: 247-255.
29. Sawa Y et al. Hypoxic myocytes promote neutrophil transendothelial migration through a CD 18 and ICAM-1 dependent mechanism. Am J Physiol (in press).
30. Morita S et al. Effects of late reperfusion on infarct expansion and infarct healing in conscious rats. Am J Pathol 1993; 143: 419-430.
31. Herskowitz A, Choi S, Ansari AA, Wesselingh S. Cytokine mRNA expression in postischemic/reperfusion myocardium. Am J Pathol 1995; 146: 419-428.
32. Kato K et al. Expression of hepatitis B virus surface antigen in adult rat liver. J Biol Chem 1991; 266: 3361-3364.
33. MacGregor GR et al. Use of E. coli lacZ (β-galactosidase) as a reporter gene. In: Murray EJ (ed). Methods in Molecular Biology. Vol. 7 Gene Transfer and Expression Protocols. Humana Press: Clifton, NJ, 1991, pp 217-241